Arun Upadhyay

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Malvern, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Arun Upadhyay by Shankar Musunuri, his attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Arun Upadhyay

Form 4 holding Chief Scientific Officer, Head of Research, Development and Medical

Ocugen, Inc.

Security class
Common Stock
Shares / value
306,197
Estimated value
$273,893
Report date
03 Jan 2025
Price
$0.8945
Ownership
Direct
Form 4 holding Chief Scientific Officer, Head of Research, Development and Medical

Ocugen, Inc.

Security class
Option (Right to Buy)
Shares / value
730,994
Estimated value
Report date
02 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Arun Upadhyay

4 OCGN

Ocugen, Inc.

Report period
02 Jan 2025
Transactions
2
Transaction value
-$37,241
Accepted by SEC
06 Jan 2025, 17:02
Role
Chief Scientific Officer, Head of Research, Development and Medical
Next action
Open filing details
4 OCGN

Ocugen, Inc.

Report period
16 Sep 2024
Transactions
1
Transaction value
-$985
Accepted by SEC
26 Sep 2024, 16:27
Role
Chief Scientific Officer, Head of Research, Development and Medical
Next action
Open filing details
4 OCGN

Ocugen, Inc.

Report period
17 Jun 2024
Transactions
1
Transaction value
-$1,302
Accepted by SEC
02 Jul 2024, 16:09
Role
Chief Scientific Officer, Head of Research, Development and Medical
Next action
Open filing details
4 OCGN

Ocugen, Inc.

Report period
03 Jan 2024
Transactions
1
Transaction value
-$27,186
Accepted by SEC
05 Jan 2024, 16:47
Role
Chief Scientific Officer, Head of Research, Development and Medical
Next action
Open filing details
4 OCGN

Ocugen, Inc.

Report period
02 Jan 2024
Transactions
1
Transaction value
$0
Accepted by SEC
04 Jan 2024, 17:04
Role
Chief Scientific Officer, Head of Research, Development and Medical
Next action
Open filing details
4 OCGN

Ocugen, Inc.

Report period
16 Sep 2023
Transactions
1
Transaction value
-$345
Accepted by SEC
19 Sep 2023, 16:01
Role
Chief Scientific Officer, Head of Research, Development and Medical
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .